QURE Message Board Post 9866842 | uniQure N.V.
home / stock / qure / qure message board
H8BeinSober215
(investorshub)
Posted on: Aug/08/2016 00:01:06
Source: investorshub
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=124371229
This trade turning into pure genius muhahahhaha
News, Short Squeeze, Breakout and More Instantly...
uniQure N.V. Company Name:
QURE Stock Symbol:
Market:
-
~ Designation based on 24-month interim Phase I/II clinical data for AMT-130 announced in December 2023 ~ ~ AMT-130 is the first therapeutic candidate to receive RMAT Designation for Huntington’s disease ~ ~ Receiving RMAT designation enables increased collaboration with ...
- QURE - uniQure Announces First Quarter 2024 Financial Results and Highlights Recent Company Progress
~ On track to initiate FDA interaction regarding AMT-130 in second quarter of 2024 and provide a clinical update from the Phase I/II trials in mid-2024 ~ ~ Clinical trial initiation for Fabry disease on track to begin in second quarter of 2024, followed by refractory mesial temporal lob...
-
~ Presented promising clinical update from U.S. and European Phase I/II trials of AMT-130 in Huntington’s disease; Up to three years of follow-up data to be presented in mid-2024; Regulatory interactions and clarity on potential strategies for clinical development expected in 2024 ~ ...